Recommended endoscopic surveillance interval for patients at high risk for pancreatic cancer

What is the recommended endoscopic surveillance interval for patients at high risk for pancreatic cancer? 

There is currently no consensus for the optimum endoscopic surveillance interval in individuals determined to be at increased risk for pancreatic neoplasia. Some medical centers advocate surveillance EUS in high-risk patients every 2 to 3 years, with the interval decreasing to every 12 months as the patient approaches the age when pancreatic cancer developed in the youngest affected relative.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top